CEREBYX

Pfizer Laboratories Div Pfizer Inc🇺🇸 United States

FDA Page

Effective Date: May 10, 2022
Approval ID: de5a6711-4abb-4c3d-a18b-266b094ace11
Products: 2 registered
Version: 28

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use CEREBYX safely and effectively. See full prescribing information for CEREBYX. CEREBYX (fosphenytoin sodium) injection, for intravenous or intramuscular use Initial U.S. Approval: 1996

Quick Stats

Total Products2

Labelers2

Label Sections40

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.